97 related articles for article (PubMed ID: 34337046)
1. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
Wang Y; Zhang L; Wang B; Cheng Y
Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
[TBL] [Abstract][Full Text] [Related]
2. A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification.
Yang W; An L; Li Y; Qian S
Aging (Albany NY); 2023 Sep; 15(18):9408-9425. PubMed ID: 37768206
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer.
Sheng N; He C; Jin X; Meng Q; Gu P; Ding S; Liu H; Xu Y
J Gene Med; 2024 Jan; 26(1):e3581. PubMed ID: 37605936
[TBL] [Abstract][Full Text] [Related]
4. The Integrated Prediction of Clinical and Pathological Factors on the Prognosis of Intrahepatic Cholangiocarcinoma.
Chen G; Li S; Xia A; Xing Y; Liang W
Am Surg; 2024 Jun; 90(6):1481-1490. PubMed ID: 38549438
[TBL] [Abstract][Full Text] [Related]
5. An Activated Dendritic-Cell-Related Gene Signature Indicative of Disease Prognosis and Chemotherapy and Immunotherapy Response in Colon Cancer Patients.
Ouyang Y; Yu M; Liu T; Suo M; Qiao J; Wang L; Li N
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958942
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer.
Geng X; Chen C; Huang Y; Hou J
Int J Med Sci; 2020; 17(11):1550-1560. PubMed ID: 32669958
[No Abstract] [Full Text] [Related]
7. Anoikis Patterns in Cervical Cancer: Identification of Subgroups and Construction of a Novel Risk Model for Predicting Prognosis and Immune Response.
Xiang X; Ding J
Front Biosci (Landmark Ed); 2023 Nov; 28(11):287. PubMed ID: 38062824
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a prognostic model for tongue cancer based on three genes signature.
Tan H; Huang H; Yang H; Qian J; Wei L; Liu W
Medicine (Baltimore); 2023 Nov; 102(46):e36097. PubMed ID: 37986320
[TBL] [Abstract][Full Text] [Related]
9. A novel epigenetic signature for overall survival prediction in patients with breast cancer.
Bao X; Anastasov N; Wang Y; Rosemann M
J Transl Med; 2019 Nov; 17(1):380. PubMed ID: 31747912
[TBL] [Abstract][Full Text] [Related]
10. A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer.
Qi X; Fu Y; Sheng J; Zhang M; Zhang M; Wang Y; Li G
Bioengineered; 2021 Dec; 12(1):1813-1825. PubMed ID: 33989111
[TBL] [Abstract][Full Text] [Related]
11. Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
Wang L; Qu H; Ma X; Liu X
Oxid Med Cell Longev; 2022; 2022():1056825. PubMed ID: 36225179
[TBL] [Abstract][Full Text] [Related]
12. Identification of a prognostic model based on immune and hypoxia-related gene expressions in cervical cancer.
Wang L; Wang C; He Y; Jin M; Lin L; Jiao X; Hu X; Wang Y
J Obstet Gynaecol; 2023 Dec; 43(2):2277242. PubMed ID: 37938121
[TBL] [Abstract][Full Text] [Related]
13. A novel NET-related gene signature for predicting DLBCL prognosis.
Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z
J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978
[TBL] [Abstract][Full Text] [Related]
14. Influencing factors and risk prediction model for cervical cancer recurrence.
Li J; Luo J; Liu G; Yan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1711-1720. PubMed ID: 36748382
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database.
He JY; Li ZM; Chen YT; Zhao BH; Yu C
Transl Cancer Res; 2024 Apr; 13(4):1721-1736. PubMed ID: 38737688
[TBL] [Abstract][Full Text] [Related]
16. Prognostic assessment of lung adenocarcinoma patients with early-staging diseases: a nomogram based on coagulation-related factors.
Wu LL; Lin WK; Qian JY; Ma SS; Li MJ; Li K; Li ZX; Lan G; Xie D
Eur J Cardiothorac Surg; 2023 Nov; 64(5):. PubMed ID: 37699000
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer.
Gu Z; Yang C; Zhang K; Wu H
BMC Cancer; 2024 Apr; 24(1):492. PubMed ID: 38637740
[TBL] [Abstract][Full Text] [Related]
18. Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients.
Pan B; Xu Y; Yao R; Cao X; Zhou X; Hao Z; Zhang Y; Wang C; Shen S; Luo Y; Zhu Q; Ren X; Kong L; Zhou Y; Sun Q
J Transl Med; 2023 Nov; 21(1):798. PubMed ID: 37946210
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer.
Cheng TC; Wu JH; Zhu B; Gao HY; Zheng L; Chen WX
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16779-16795. PubMed ID: 37728703
[TBL] [Abstract][Full Text] [Related]
20. Construction of prognostic risk markers for cervical cancer combined with anoikis-related genes and their clinical significance.
Zhang J; Tian Y
Reprod Fertil Dev; 2023 Nov; 35(16):677-691. PubMed ID: 37899003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
